心血管,腎臓,代謝の健康: 心不全の予防のための実行可能なビジョン
John W Ostrominski1, Alice Y Y Cheng2, Adam J Nelson3
1Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Lancet (London, England)
|September 1, 2025
まとめ
心不全の予防は 病院での入院が増加しているため 極めて重要です 心血管,腎臓,代謝の健康に重点を置くと 予防戦略の新たな枠組みが生まれます
科学分野:
- 心臓病科
- 腎臓科
- 代謝医学
背景:
- 心不全は 世界的に 予防可能な入院の 主な原因です
- 歴史的に見れば 心臓不全は 複雑で多系統的な原因だと理解されています
- 心血管,腎臓,代謝疾患はしばしば心不全の発生に先行し,それに寄与する.
研究 の 目的:
- 心血管,腎臓,代謝 (CKM) 疾患が心不全の病原性に関連していることを強調する.
- CKM健康を統合することで心不全の予防のための実行可能な枠組みを提案する.
- CKM疾患に寄与する病理学的および社会構造的要因に対処する重要性を強調する.
主な方法:
- 心不全の危険因子に関する疫学研究のレビュー
- CKMの健康に影響を与える薬剤療法に関する臨床試験データの分析
- CKM疾患と心不全の発生と進行を関連付ける証拠のまとめ
主要な成果:
- 流行病学的なデータは,心臓機能不全において,心血管,腎臓,代謝機能障害の頻繁な同時発生を確認している.
- 新興の薬剤療法では,CKMの健康状態を同時に改善することが示されています.
- 流行病学的および治療的証拠の収束は,共通の病気のメカニズムを示しています.
結論:
- 心不全の予防には 心血管,腎臓,代謝の健康を含む より広い視野が必要です
- CKMの疾患とその前例は 心不全の予防において 重要で しばしば見過ごされる標的です
- 統合されたCKMの健康アプローチは,心不全の予防における様々な利害関係者にとって実用的な枠組みを提供します.
関連する概念動画
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27